[TRP channels as targets for novel calcium antagonists].
Kiyonaka
Shigeki
S
kiyonaka@sbchem.kyoto-u.ac.jp
Mori
Yasuo
Y
D000813:Anilides; D001896:Boron Compounds; D002118:Calcium / Q000502:physiology; D002121:Calcium Channel Blockers; D015195:Drug Design; D006801:Humans; D007093:Imidazoles; D015290:Second Messenger Systems / Q000502:physiology; D050052:TRPC Cation Channels / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology; D013830:Thiadiazoles
C476308:4-methyl-4'-(3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl)-1,2,3-thiadiazole-5-carboxanilide; D000813:Anilides; D001896:Boron Compounds; D002121:Calcium Channel Blockers; D007093:Imidazoles; D050052:TRPC Cation Channels; D013830:Thiadiazoles; C109986:2-aminoethoxydiphenyl borate; C063159:1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole; D002118:Calcium